Hexagon Nutrition Peer Comparison

NSE: HEXAGON | BSE: 544785

₹59.21

₹-2.37 (-3.85%)

As on 09-Nov-2026IST

Market cap

₹728 Cr

Revenue (TTM)

₹383 Cr

P/E Ratio

19.2

P/B Ratio

3.2

Div. Yield

0.5 %

Edit

	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma
Market cap (₹ Cr)	728	831	39,025	14,806	13,986
Revenue (₹ Cr)	383	2,033	2,371	4,131	3,392
Net Profit (₹ Cr)	37.94	84.15	376.21	411.10	565.65
Net Margin (%)	9.59	4.08	15.66	9.78	16.21
RoE (%)	18.82	15.28	14.78	13.13	17.62
Price to Earnings	19.19	10.49	103.73	36.01	24.98
Price-To-Book	3.16	1.55	14.52	4.41	4.20

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma
Operating Revenue	382.63	1,449.45	2,192.49	3,510.50	2,950.94
Total Income	395.48	1,478.13	2,266.90	3,582.50	3,033.47
Total Expenditure	330.94	1,334.87	1,584.97	2,891.50	2,350.16
EBITDA	51.69	114.58	607.53	619.00	600.78
Depreciation	9.64	16.59	166.86	126.40	98.63
EBIT	42.05	97.99	440.67	492.60	502.15
Interest	4.02	53.60	40.88	19.30	24.13
Other Income	12.85	28.68	74.40	72.00	82.53
Exceptional Items	0.31	--	-8.00	-20.30	--
Profit before Tax	51.18	75.14	466.19	525.00	560.56
Provision for Tax	13.24	18.06	117.28	123.90	140.49
Profit after Tax	37.94	57.09	348.91	401.10	420.06

Liabilities (₹ Cr)

	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma
Shareholder's Funds	233.29	499.09	2,483.69	3,138.70	3,023.16
Minority Interest	--	29.69	--	--	29.52
Non-Current Liabilities	11.80	43.05	321.65	318.60	268.17
Current Liabilities	71.32	1,048.93	904.59	1,086.20	527.09
Total Liabilities	318.40	1,621.13	3,709.93	4,620.30	3,855.82

Assets (₹ Cr)

	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma
Non-Current Assets	75.03	331.92	2,228.49	1,925.10	1,125.20
Current Assets	241.38	1,288.83	1,481.44	2,618.40	2,722.74
Total Assets	318.40	1,621.13	3,709.93	4,620.30	3,855.82
Total Debt*	30.31	767.77	95.13	0.00	29.59
Net Current Assets	170.06	239.90	576.85	1,532.20	2,195.65
Contingent Liabilities	5.60	61.31	97.31	--	--

Cashflow (₹ Cr)

	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma
Cash From Operating Activities	6.23	-111.27	509.13	650.80	458.13
Cash Flow from Investing Activities	-5.69	-145.98	-395.41	-512.40	-248.27
Cash from Financing Activities	-0.42	267.05	-123.68	-82.60	-70.93
Net Cash Inflow / Outflow	0.12	9.81	-9.96	55.80	138.93

Ratios

Profitability Ratios

	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma
ROCE (%)	22.79	11.93	20.97	18.92	21.10
ROE (%)	18.82	12.15	15.16	14.14	15.31
ROA (%)	13.18	4.23	10.09	10.31	11.85
EBIT Margin (%)	16.87	9.88	31.10	19.68	23.16
Net Margin (%)	9.59	3.86	15.39	11.20	13.85
Cash Profit Margin (%)	12.06	4.98	23.50	15.03	17.07

Growth Ratios

	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma
Revenue Growth (%)	17.76	44.02	29.38	23.64	12.51
EBIT Growth (%)	36.66	30.24	53.37	7.72	14.07
Net Profit Growth (%)	56.09	18.69	105.08	-1.38	9.79
EPS Growth (%)	56.09	12.06	101.82	-1.79	9.81
Book Value Growth (%)	21.49	13.25	16.76	19.89	22.41

Valuation Ratios

	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma
Price / Earnings	0.00	10.60	58.91	26.06	17.04
Price / Book Value	0.00	1.11	8.29	3.38	2.36
Dividend Yield (%)	--	0.00	0.00	0.52	0.57
EV/EBITDA	0.55	8.79	30.12	14.57	9.02
Market Cap (₹ Cr)	0.00	551.66	20,554.39	10,450.76	7,121.50

Solvency Ratios

	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma
Debt to Equity	0.13	1.54	0.04	0.00	0.01
Short term debt to equity ratio	0.09	1.44	0.03	--	0.01
Current Ratio	3.38	1.23	1.64	2.41	5.17
Quick Ratio	2.21	0.41	1.47	2.41	3.32
Interest Coverage	13.73	2.40	12.40	28.20	24.24

Operating Efficiency Ratios

	Hexagon Nutrition	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma
Debtors to sales (%)	21.36	12.55	17.04	27.97	21.84
Asset Turnover	1.37	1.10	0.63	0.90	0.86
Receivable days	65.47	47.06	60.56	90.10	71.16
Inventory Days	67.12	175.18	22.43	0.00	109.20
Payable days	43.55	59.68	194.31	--	91.82
Cash Conversion Cycle	89.04	162.56	-111.32	--	88.55